Nova Ltd vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Nova Ltd trades at $366.27 (market cap $12.03B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.16B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 4.8× Nova Ltd's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.36% dividend while Nova Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nova Ltd for 5 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days on average.
| NVMI | TAK | |
|---|---|---|
Market Cap | $12.03B | $58.16B |
Volume | 283,357 | 2,467,530 |
Sector | Technology | Health |
52-Week High | $605.65 | $19.05 |
52-Week Low | $275.78 | $13.23 |
Typical Hold Time | 5 Days | 0 Days |
Enterprise Value | $11.82B | $86.04B |
Dividend Yield | — | 3.36% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Nova provides metrology solutions for semiconductor manufacturing. Its systems measure material and process characteristics to help chipmakers control production across advanced nodes and packaging.
Read more on NVMI →Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →